… to economic modelling. Indeed, no trial has ever been planned with the power to compare
directly CRT-D and CRT-P, and the COMPANION study is the only trial to include patients …

… All economic evaluations, including our own model, are … Second, the economic evaluations
are limited by the external … results of the economic models may be biased in favour of CRT. …

… A number of published economic … economic models evaluating CRT-D devices for patients
with heart failure (HF), compare the structure and inputs of the cost-effectiveness models, and …

… the use of cardiac resynchronization therapy (CRT) in advanced heart failure, but its cost-effectiveness
is still unclear. This analysis assessed the economic and health consequences in …

… Economic model … Economic model based on HF patients (NYHA functional class III–IV)
enrolled in the CARE-HF trial. Survival data for CRT-D from the COMPANION trial Markov model …

… This article will consider how economic tools may help … We will address the question of
how economic approaches, … modelling assumptions/contexts (Table 2). The diversity in the …

… cardiac resynchronisation therapy (CRT) for people with heart failure and evidence of
dyssynchrony by comparing cardiac resynchronisation … of the review of economic evaluations, for …

… The aim of this study was to compare the cost effectiveness of cardiac … cardiac
resynchronisation (biventricular pacing) for heart failure: systematic review and economic model …

… The health economic model distinguishes between a short-term (represented by the
process of device implantation and classification) and a long-term phase (represented by post-…

… During the randomization period that informed our statistical modelling the pacing was <1%
in all such patients. Therefore, even if backup pacing could have introduced bias, this did not …